Sugi Predict

Sugi Predict / Compounds / SCHEMBL19973964

SCHEMBL19973964

SCHEMBL19973964

Nc1cc(C(=O)Nc2ccc(F)c(F)c2)c2c(c1)[C@@H](NC(=O)O)CCO2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 1/20 0.41
▸ TP53 P04637 2/20 0.40
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ RAB9A P51151 7/20 0.39
▸ NPC1 O15118 6/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ MAPT P10636 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ ENPP2 Q13822 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ DGAT1 O75907 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19973966 1.00 MAOB (0.41) MAOBTP53CYP3A4CYP2D6CYP2C9
SCHEMBL19973430 0.89 MAOB (0.39) MAOBTP53CYP3A4CYP2D6CYP2C9
SCHEMBL19973429 0.89 MAOB (0.39) MAOBTP53CYP3A4CYP2D6CYP2C9
SCHEMBL21189358 0.89 MAOB (0.39) MAOBTP53CYP3A4CYP2D6CYP2C9
SCHEMBL19973432 0.86 TP53 (0.46) MAOBTP53RAB9ANPC1LMNA
SCHEMBL19973433 0.86 TP53 (0.46) MAOBTP53RAB9ANPC1LMNA
SCHEMBL19973586 0.86 TP53 (0.46) MAOBTP53RAB9ANPC1LMNA
Hydrochloric Acid SCHEMBL19973574 0.85 TP53 (0.46) MAOBTP53RAB9ANPC1LMNA
Hydrochloric Acid SCHEMBL19973580 0.85 TP53 (0.46) MAOBTP53RAB9ANPC1LMNA
SCHEMBL19973532 0.85 MAPT (0.39) MAOBTP53RAB9ANPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 — — US claimed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 — — WO claimed
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 — — US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 — — US disclosed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME CBX8, HAVCR2, HCCS MAOB 1792/4885TP53 166/4885CYP3A4 269/4885
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same CBX8, HAVCR2, HCCS MAOB 1792/4885TP53 166/4885CYP3A4 269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.